We use advanced imaging technology to detect disease biomarkers throughout the eye
1 / Eye Examination
We take images by combining standard equipment available in most eye clinics with a specialized camera -- this means that the experience is familiar and comfortable.
2 / Data-Rich Images
Our hyperspectral camera can captures data-rich images with a broad spectrum of information, providing the basis for detailed analysis of a large area for more accurate results
3 / Artificial Intelligence
Our AI identifies early signs of Alzheimer’s disease by comparing the captured images to others where the biological signatures associated with these neurodegenerative diseases are present.
Clinical and Postmortem Analysis of Retinal Tissue
Benjamin Danner, Carlos Zamudio, Callen Spencer, Jaclyn Lilek, Arleen Matos, Meaghan Morris, Kaouther Ajroud, Margaret E. Flanagan
In Vivo Assessment of Retinal Biomarkers by Hyperspectral Imaging: Early Detection of Alzheimer's Disease
Swati S More, James M Beach, Collin McClelland, Ali Mokhtarzadeh, Robert Vince
ACS Chem Neurosci. 2019 Nov 20;10(11):4492-4501. doi: 10.1021/acschemneuro.9b00331. Epub 2019 Oct 24.
Early Detection of Amyloidopathy in Alzheimer's Mice by Hyperspectral Endoscopy
Swati S. More; James M. Beach; Robert Vince
Investigative Ophthalmology & Visual Science June 2016, Vol.57, 3231-3238. doi:https://doi.org/10.1167/iovs.15-17406
Hyperspectral Imaging Signatures Detect Amyloidopathy in Alzheimer’s Mouse Retina Well before Onset of Cognitive Decline; ACS Chem.
Swati S. More and Robert Vince
ACS Chem. Neurosci. 2015, 6, 2, 306-315 https://doi.org/10.1021/cn500242z
We partner with pharmaceutical companies and leading research institutions to accelerate research and integrate seamlessly into the clinical workflow